Treatment of acute uncomplicated cystitis with faropenem for 3 days versus 7 days: multicentre, randomized, open-label, controlled trial | Zendy

Ryoichi Hamasuna | Zendy; K. Tanaka | Zendy; Hiroshi Hayami | Zendy; Mitsuru Yasuda | Zendy; Satoshi Takahashi | Zendy; Kanao Kobayashi | Zendy; Hiroshi Kiyota | Zendy; Shingo Yamamoto | Zendy; Soichi Arakawa | Zendy; Tetsuro Matsumoto | Zendy; Kiyohito Ishikawa | Zendy; Satoshi Ishihara | Zendy; Shuichiro Uehara | Zendy; Shinichi Onodera | Zendy; S. Kanemaru | Zendy; Toshihiro Kikuchi | Zendy; Hiromi Kumon | Zendy; Hiroshi Shima | Zendy; Atsushi Takahashi | Zendy; Yuichiro Kurimura | Zendy; Masanobu Tanimura | Zendy; Tadashi Tsukamoto | Zendy; T. Deguchi | Zendy; Seiji Naito | Zendy; Yoshiaki Nakano | Zendy; M. Fujisawa | Zendy; Takako Miura | Zendy; M. Yasada | Zendy; Tomihiko Yasufuku | Zendy; Takashi Yamane | Zendy; Kodai Wada | Zendy; Toyohiko Watanabe | Zendy; Hiroshi Nagae | Zendy; Takehiko Sho | Zendy; Hiroyuki Nose | Zendy; M. Kusaka | Zendy; Mineo Matsumoto | Zendy; K. Kobayahsi | Zendy; Akio Matsubara | Zendy; Hironobu Wakeda | Zendy; Shin Ito | Zendy; Y. Yamada | Zendy; Kazumi Fujita | Zendy; Yoshikazu Togo | Zendy; Tatsuhiko Kubo | Zendy; Y. Aoki | Zendy; Masanori Matsukawa | Zendy; Susumu Yazawa | Zendy; Tadahiko Karasawa | Zendy; Jun Miyazaki | Zendy; Hiroyuki Nishiyama | Zendy; Rikiya Taoka | Zendy; Katsunori Shigehara | Zendy; Jonathan Hashimoto | Zendy; H. Betsuno | Zendy; Jun Kamei | Zendy; Hiroshi Hongo | Zendy

Open Access

Treatment of acute uncomplicated cystitis with faropenem for 3 days versus 7 days: multicentre, randomized, open-label, controlled trial

Author(s) -

Ryoichi Hamasuna,

K. Tanaka,

Hiroshi Hayami,

Mitsuru Yasuda,

Satoshi Takahashi,

Kanao Kobayashi,

Hiroshi Kiyota,

Shingo Yamamoto,

Soichi Arakawa,

Tetsuro Matsumoto,

Kiyohito Ishikawa,

Satoshi Ishihara,

Shuichiro Uehara,

Shinichi Onodera,

S. Kanemaru,

Toshihiro Kikuchi,

Hiromi Kumon,

Hiroshi Shima,

Atsushi Takahashi,

Yuichiro Kurimura,

Masanobu Tanimura,

Tadashi Tsukamoto,

T. Deguchi,

Seiji Naito,

Yoshiaki Nakano,

M. Fujisawa,

Takako Miura,

M. Yasada,

Tomihiko Yasufuku,

Takashi Yamane,

Kodai Wada,

Toyohiko Watanabe,

Hiroshi Nagae,

Takehiko Sho,

Hiroyuki Nose,

M. Kusaka,

Mineo Matsumoto,

K. Kobayahsi,

Akio Matsubara,

Hironobu Wakeda,

Shin Ito,

Y. Yamada,

Kazumi Fujita,

Yoshikazu Togo,

Tatsuhiko Kubo,

Y. Aoki,

Masanori Matsukawa,

Susumu Yazawa,

Tadahiko Karasawa,

Jun Miyazaki,

Hiroyuki Nishiyama,

Rikiya Taoka,

Katsunori Shigehara,

Jonathan Hashimoto,

H. Betsuno,

Jun Kamei,

Hiroshi Hongo

Publication year - 2014

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dku014

Subject(s) - antimicrobial , medicine , randomized controlled trial , antibiotics , microbiology and biotechnology , anaerobic bacteria , bacteria , anaerobic exercise , antibacterial agent , pharmacology , biology , physiology , genetics

The increasing prevalence of resistant bacteria such as fluoroquinolone-resistant or extended-spectrum β-lactamase-producing strains in pathogens causing acute uncomplicated cystitis has been of concern in Japan. Faropenem sodium is a penem antimicrobial that demonstrates a wide antimicrobial spectrum against both aerobic and anaerobic bacteria. It is stable against a number of β-lactamases.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research